Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron Efficacy and Safety in OAB Patients in Taiwan
NCT03059134Phase 3Completed
- Sponsor
- Buddhist Tzu Chi General Hospital
- Start
- Apr 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of mirabegron in overactive bladder syndrome (OAB), sponsored by Buddhist Tzu Chi General Hospital. Started Apr 2015; status: completed.
02
Drugs
mirabegron
03
Conditions
overactive bladder syndrome (OAB)
Beyond the preview
Go deeper on NCT03059134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03059134.